Price Erin P, Sarovich Derek S, Nosworthy Elizabeth, Beissbarth Jemima, Marsh Robyn L, Pickering Janessa, Kirkham Lea-Ann S, Keil Anthony D, Chang Anne B, Smith-Vaughan Heidi C
Child Health Division, Menzies School of Health Research, Darwin, NT, Australia.
Menzies School of Health Research, PO Box 41096, Casuarina, NT, 0811, Australia.
BMC Genomics. 2015 Aug 27;16(1):641. doi: 10.1186/s12864-015-1857-x.
Haemophilus influenzae is an opportunistic bacterial pathogen that exclusively colonises humans and is associated with both acute and chronic disease. Despite its clinical significance, accurate identification of H. influenzae is a non-trivial endeavour. H. haemolyticus can be misidentified as H. influenzae from clinical specimens using selective culturing methods, reflecting both the shared environmental niche and phenotypic similarities of these species. On the molecular level, frequent genetic exchange amongst Haemophilus spp. has confounded accurate identification of H. influenzae, leading to both false-positive and false-negative results with existing speciation assays.
Whole-genome single-nucleotide polymorphism data from 246 closely related global Haemophilus isolates, including 107 Australian isolate genomes generated in this study, were used to construct a whole-genome phylogeny. Based on this phylogeny, H. influenzae could be differentiated from closely related species. Next, a H. influenzae-specific locus, fucP, was identified, and a novel TaqMan real-time PCR assay targeting fucP was designed. PCR specificity screening across a panel of clinically relevant species, coupled with in silico analysis of all species within the order Pasteurellales, demonstrated that the fucP assay was 100 % specific for H. influenzae; all other examined species failed to amplify.
This study is the first of its kind to use large-scale comparative genomic analysis of Haemophilus spp. to accurately delineate H. influenzae and to identify a species-specific molecular signature for this species. The fucP assay outperforms existing H. influenzae targets, most of which were identified prior to the next-generation genomics era and thus lack validation across a large number of Haemophilus spp. We recommend use of the fucP assay in clinical and research laboratories for the most accurate detection and diagnosis of H. influenzae infection and colonisation.
流感嗜血杆菌是一种专性定植于人类的机会性细菌病原体,与急性和慢性疾病均有关联。尽管其具有临床重要性,但准确鉴定流感嗜血杆菌并非易事。使用选择性培养方法时,溶血嗜血杆菌可能会被临床标本误鉴定为流感嗜血杆菌,这反映了这些菌种共有的环境生态位和表型相似性。在分子水平上,嗜血杆菌属菌种之间频繁的基因交换使得流感嗜血杆菌的准确鉴定变得复杂,导致现有菌种鉴定分析出现假阳性和假阴性结果。
来自246株密切相关的全球嗜血杆菌分离株的全基因组单核苷酸多态性数据,包括本研究中生成的107株澳大利亚分离株基因组,用于构建全基因组系统发育树。基于该系统发育树,流感嗜血杆菌可与密切相关的菌种区分开来。接下来,鉴定出一个流感嗜血杆菌特异性位点fucP,并设计了一种针对fucP的新型TaqMan实时PCR检测方法。对一组临床相关菌种进行PCR特异性筛选,并结合对巴斯德菌目所有菌种的电子分析,结果表明fucP检测方法对流感嗜血杆菌具有100%的特异性;所有其他检测的菌种均未扩增。
本研究首次利用大规模的嗜血杆菌属比较基因组分析来准确界定流感嗜血杆菌,并为该菌种鉴定出一个物种特异性分子特征。fucP检测方法优于现有的流感嗜血杆菌检测靶点,其中大多数是在下一代基因组学时代之前鉴定的,因此缺乏对大量嗜血杆菌属菌种的验证。我们建议在临床和研究实验室中使用fucP检测方法,以最准确地检测和诊断流感嗜血杆菌感染和定植。